Myeloid cells from Creative Bioarray are obtained by positive selection using anti-CD33 and anti-CD66 antibodies and immunomagnetic separation techniques from bone marrow mononuclear cells (MNCs). CD33+CD66+ myeloid cells are characterized by the expression of CD14 and CD66b by flow cytometry.